- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 13/00 - Drugs for disorders of the urinary system
Patent holdings for IPC class A61P 13/00
Total number of patents in this class: 948
10-year publication summary
|
37
|
43
|
58
|
65
|
82
|
61
|
71
|
40
|
38
|
34
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer AG | 3495 |
23 |
| Allergan, Inc. | 2169 |
18 |
| Bayer Pharma AG | 1014 |
18 |
| F. Hoffmann-La Roche AG | 7836 |
16 |
| Astellas Pharma Inc. | 1043 |
15 |
| Takeda Pharmaceutical Company Limited | 2715 |
11 |
| Shionogi & Co., Ltd. | 873 |
11 |
| Santa Farma İlaç Sanayi̇ A.ş. | 67 |
9 |
| Boehringer Ingelheim International GmbH | 4493 |
8 |
| Novartis AG | 10263 |
7 |
| AstraZeneca AB | 2818 |
7 |
| Janssen Pharmaceutica N.V. | 3171 |
6 |
| Pfizer Inc. | 3384 |
6 |
| Vertex Pharmaceuticals Incorporated | 1584 |
6 |
| sanofi-aventis | 302 |
6 |
| Janssen Pharmaceuticals, Inc. | 435 |
5 |
| Merck Patent GmbH | 5725 |
5 |
| Angion Biomedica Corp. | 59 |
5 |
| Dainippon Sumitomo Pharma Co., Ltd. | 167 |
5 |
| Nippon Shinyaku Co., Ltd. | 322 |
5 |
| Other owners | 756 |